New use of BCG for recombinant vaccines
C. Kendall Stover(Telesis Corporation (United States)), Barry R. Bloom(Yeshiva University)
Cited by 1,492
Related Papers
Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine.
|The Journal of Experimental Medicine|1993|269
Interferon-gamma-induced transcriptional activation is mediated by protein kinase C.
|Proceedings of the National Academy of Sciences|1988|136
A T Helper Cell 2 (Th2) Immune Response against Non-self Antigens Modifies the Cytokine Profile of Autoimmune T Cells and Protects against Experimental Allergic Encephalomyelitis
|The Journal of Experimental Medicine|1997|135